TCON
TRACON Pharmaceuticals Inc

8,517
Loading...
Loading...
News
all
press releases
TRACON Pharmaceuticals Provides Update on Ongoing ENVASARC Phase 2 Pivotal Trial Following Independent Data Monitoring Committee Recommendation to Continue the Trial as Planned
ENVASARC Trial is Fully Enrolled and Final Data are Expected in Third Quarter 2024 SAN DIEGO, April 03, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage...
Globe Newswire·1y ago
News Placeholder
More News
News Placeholder
Buy Rating for TRACON Pharmaceuticals on Strong Financials and Promising Clinical Trials
Maxim Group analyst Jason McCarthy maintained a Buy rating on TRACON Pharmaceuticals (TCON Research Report) yesterday and set a price target of...
TipRanks Financial Blog·2y ago
News Placeholder
Tracon Pharmaceuticals reports Q4 EPS 1c, consensus (8c)
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago
News Placeholder
Tracon Pharmaceuticals reports Q4 EPS 1c, consensus (8c)
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago
News Placeholder
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
SAN DIEGO, March 05, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development...
Globe Newswire·2y ago
News Placeholder
TRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5, 2024
SAN DIEGO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development...
Globe Newswire·2y ago

Latest TCON News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.